Short answer
ARDELYX, INC. (ARDX) filed an 8-K current report with the SEC on August 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 results announced for quarter ended June 30, 2026.
ARDELYX, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 results announced for quarter ended June 30, 2026
- Full financial results and management commentary contained in Exhibit 99.1
- Earnings disclosure enables investors to assess quarterly operating performance and financial condition
Item 7.01 · Regulation FD Disclosure
- Earnings presentation for quarter ended June 30, 2026 furnished as Exhibit 99.2
- Conference call scheduled for August 6, 2026, providing management commentary on quarterly results
Item EX-99.1 · Exhibit EX-99.1
- Q2 product revenue $118.1M, up 31% YoY, with IBSRELA $86.2M and XPHOZAH $31.9M
- IBSRELA guidance cut to $350–$370M as payor utilization management pressures near-term growth
- XPHOZAH guidance maintained at $110–$120M, but long-term guidance withdrawn amid evolving market dynamics
- Cash, equivalents and investments $281.8M; $50M financing draw increases flexibility but raises long-term debt to $251.8M
- Net loss narrowed to $16.7M from $19.1M despite R&D rising to $26.1M and SG&A to $101.4M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ARDELYX, INC. 8-K filings
Get the next ARDX 8-K as it lands
Follow ARDX for push alerts, or ask the research agent what this filing means.